Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells

被引:24
作者
Bunyaratavej, P
Hullinger, TG
Somerman, MJ
机构
[1] Univ Michigan, Sch Dent, Dept Periodont Prevent Geriatr, Ann Arbor, MI 48109 USA
[2] Chiang Mai Univ, Fac Dent, Dept Periodontol, Chiang Mai, Thailand
[3] Pfizer Global Res & Dev, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
bone morphogenetic proteins; breast cancer; osteoblasts; bone sialoprotein;
D O I
10.1006/excr.2000.5019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is well established that bone metastases comprise bone; however, the exact factors/mechanisms involved remain unknown. We hypothesized that tumor cells secreted factors capable of altering normal bone metabolism. The aims of the present study were to (1) determine the effects of secretory products isolated from HT-39 cells, a human breast cancer cell line, on osteoprogenitor cell (MC3T3-E1 cells) behavior, and (2) identify tumor-derived factor(s) that alters osteoblast activities. Conditioned media (CM) from HT-39 cells were collected following a 24-h serum-free culture. The ability of CM to alter gene expression in MC3T3-E1 cells was determined by Northern analysis. CM effects on cell proliferation and mineralization ability were determined using a Coulter counter and von Kossa stain, respectively. MC3T3-E1 cells were treated with CM plus noggin, a factor known to block bone morphogenic proteins (BMPs), to determine whether BMPs, shown to be present in CM, were linked with CM effects on MC3T3-E1 cell activity. In addition, inhibitors of MAP kinase kinase (MEK), protein kinase C (PKC), and protein kinase A were used to identify the intracellular signaling pathway(s) by which the active factors in CM regulated osteoblast behavior. CM treatment significantly enhanced BSP mRNA (2.5-fold over control), but had no effect on cell proliferation. Mineralization assay showed that CM enhanced mineral nodule formation compared to controls. Noggin inhibited CM-induced upregulation of BSP mRNA, suggesting that BMPs were responsible for upregulating BSP gene expression in MC3T3-E1 cells. The PKC inhibitor blocked CM-mediated upregulation of BSP, suggesting involvement of the PKC pathway in regulating BSP expression. BMPs secreted by HT-39 cells may be responsible for enhancing BSP expression in MC3T3-E1 cells. Continued studies targeted at determining the role of BMPs in regulating bone metabolism are important for understanding the pathogenesis of bone diseases. (C) 2000 Academic Press.
引用
收藏
页码:324 / 333
页数:10
相关论文
共 78 条
  • [1] Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: Importance of BMP2
    Arnold, SF
    Tims, E
    McGrath, BE
    [J]. CYTOKINE, 1999, 11 (12) : 1031 - 1037
  • [2] Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells
    Asahina, I
    Sampath, TK
    Hauschka, PV
    [J]. EXPERIMENTAL CELL RESEARCH, 1996, 222 (01) : 38 - 47
  • [3] OSTEOBLAST AND CHONDROBLAST DIFFERENTIATION
    AUBIN, JE
    LIU, F
    MALAVAL, L
    GUPTA, AK
    [J]. BONE, 1995, 17 (02) : S77 - S83
  • [4] Barnes J, 1995, WORLD J UROL, V13, P337
  • [5] Bellahcene A, 1996, LAB INVEST, V75, P203
  • [6] Bellahcene A, 1997, B CANCER, V84, P17
  • [7] Bellahcene A, 1996, J BONE MINER RES, V11, P665
  • [8] EXPRESSION OF BONE SIALOPROTEIN (BSP) IN DEVELOPING HUMAN TISSUES
    BIANCO, P
    FISHER, LW
    YOUNG, MF
    TERMINE, JD
    ROBEY, PG
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1991, 49 (06) : 421 - 426
  • [9] BOYDE A, 1986, Scanning Electron Microscopy, P1537
  • [10] Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
    Brunet, LJ
    McMahon, JA
    McMahon, AP
    Harland, RM
    [J]. SCIENCE, 1998, 280 (5368) : 1455 - 1457